首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷手術用器具顯微鏡

市場調查報告書

商品編碼

1836356

2032 年自動顯微鏡市場預測：按產品類型、應用、最終用戶和地區進行的全球分析

Automated Microscopy Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User and By Geography

出版日期: 2025年10月01日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球自動顯微鏡市場預計在 2025 年達到 88.2 億美元，到 2032 年將達到 156.2 億美元，預測期內的複合年成長率為 8.5%。

自動顯微鏡代表了實驗室研究和醫學診斷領域的重大進步，能夠在有限的人力資源下對生物樣本進行快速成像和詳細檢查。這些平台結合了機器人技術、尖端光學系統和智慧軟體，能夠有效地捕捉、處理和評估海量影像，從而提高速度和準確性。自動顯微鏡常用於細胞生物學、病理學、藥物檢測和臨床分析等領域，可確保結果的一致性和重複性。最大限度地減少人工操作可加快資料收集速度，並支援進階定量研究，例如細胞計數、結構分析和螢光測量。這項技術對於提高研究效率、診斷準確性和實驗一致性至關重要。

根據美國國立衛生研究院 (NIH) 的數據，到 2023 年，美國美國用於生物醫學研究的資金將超過 450 億美元，其中大部分將用於癌症、神經科學和感染疾病研究的成像技術。自動化顯微鏡系統對於這些領域的高通量成像至關重要。

高通量影像處理的需求不斷成長

生物醫學研究和醫療診斷領域對高速成像的需求日益成長，大大推動了自動化顯微鏡市場的發展。傳統的手動顯微鏡不足以有效率地處理大量樣本。自動化平台能夠實現快速、準確且可重複的成像，從而實現廣泛的樣本分析，同時減少人力成本。基因組學、藥物開發和個人化醫療等領域的技術創新推動了這一需求，這些領域需要快速分析大量數據。自動化顯微鏡可以最大限度地減少錯誤，加快實驗工作流程，提高生產率，並支持大規模研究和臨床評估，這些研究和臨床評估需要影像擷取和樣本評估的一致性、準確性和效率。

自動顯微鏡系統高成本

自動顯微鏡系統高的初始購置成本和持續維護成本是市場擴張的主要障礙。配備先進光學元件、機器人技術和整合軟體的先進平台需要大量投資，小型實驗室和研究機構難以承受。定期維護、軟體更新和員工培訓的需求進一步增加了營運成本。這些經濟挑戰阻礙了其普及，尤其是在預算有限的開發中地區。雖然自動化系統在效率和準確性方面具有優勢，但購買和操作此類設備的高昂成本是其在全球科學研究和臨床診斷領域廣泛應用的主要障礙。

與人工智慧和機器學習的整合

自動顯微鏡與人工智慧 (AI) 和機器學習 (ML) 的整合帶來了巨大的市場機會。機器學習演算法可以處理和解讀複雜的影像資料集，識別細微趨勢，並產生超越手動方法的預測性洞察。這種整合提高了實驗的準確性、速度和可重複性，從而能夠有效地進行大規模研究。在藥物研發、臨床診斷和高內涵篩檢，AI 增強影像技術的應用日益廣泛，凸顯了其優勢。將智慧演算法與自動顯微鏡結合，可擴展應用範圍、簡化工作流程並支援明智的決策。隨著 AI主導解決方案的不斷發展，與自動顯微鏡的整合為科研和醫療保健領域的創新和市場拓展提供了重要途徑。

市場主體競爭激烈

自動顯微鏡市場面臨現有參與者和新進者的激烈競爭，對成長構成了重大威脅。主要企業定期推出創新解決方案，這帶來了價格壓力，並要求產品不斷升級。由於資金有限和知名度低，中小企業可能難以維持市場佔有率。競爭壓力可能導致利潤率下降，並增加研發和行銷支出。激烈的競爭和技術的快速進步使企業難以保持長期穩定，對全球自動顯微鏡市場的永續擴張構成了重大威脅。

COVID-19的影響：

新冠疫情對自動化顯微鏡市場既有限制性影響，也有刺激性影響。初期的關閉、供應鏈中斷以及實驗室准入受限，導致設備採購和正在進行的研究活動被推遲。許多研究和臨床實驗室的運作減少，暫時阻礙了常規成像和樣本分析。然而，疫情也刺激了疫苗研究、病毒檢測和抗病毒藥物篩檢領域對自動化顯微鏡平台的需求。這些系統能夠實現快速、高通量成像，並準確監測細胞反應。因此，儘管疫情帶來了短期挫折，但它凸顯了自動化在診斷和生物醫學研究中的關鍵作用，最終推動了自動化顯微鏡市場的長期成長機會。

倒置顯微鏡市場預計將成為預測期內最大的市場

倒置顯微鏡因其在生物醫學和生命科學研究中的廣泛效用，預計將在預測期內佔據最大的市場佔有率。倒置顯微鏡可以從下方觀察活細胞和培養物，特別適合細胞研究、藥物篩檢和組織研究。它與自動化成像平台、軟體驅動分析和高通量工作流程的無縫整合，提高了實驗室的效率和精度。倒置顯微鏡提供高度可重複、精確且無損的成像，使其成為現代實驗室的重要組成部分。其支援各種實驗設計的靈活性以及與先進技術的兼容性，使其在所有自動化顯微鏡領域都佔據領先地位。

生命科學和生物醫學研究領域預計將在預測期內實現最高複合年成長率

預計生命科學和生物醫學研究領域將在預測期內達到最高成長率。這一成長源於細胞生物學、基因組學和蛋白質組學研究對先進成像技術日益成長的需求。自動化系統能夠實現快速、高通量的樣本分析、細胞成分的精細可視化以及對高級研究至關重要的精確定量測量。個人化治療、再生醫學和創新生物醫學研究的日益重視，正在推動自動化顯微鏡的強勁應用。研究機構和實驗室正在優先投資自動化顯微鏡，以提高其可重複性、效率和分析準確性，這使得生命科學和生物醫學研究成為全球成長最快的領域之一。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率，這得益於其強大的醫療保健基礎設施、眾多知名研究機構和行業領袖的支持。對生物技術、製藥和生命科學研究的大量投資正在推動對自動影像處理系統的需求。政府舉措、技術採用以及對個人化醫療的重視正在促進市場的強勁擴張。自動顯微鏡在學術、臨床和工業實驗室中廣泛應用於細胞生物學、生物醫學研究和藥物開發等應用，加強了該地區的主導地位。北美憑藉其先進的基礎設施、資金和研究專業知識，已鞏固其作為全球自動顯微鏡領先市場的地位。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。成長的動力來自醫療基礎設施投資的增加、生物技術和生命科學研究的擴展以及政府對創新和診斷的支持。製藥和生物製藥產業的快速發展推動了實驗室、研究中心和臨床機構對自動化成像平台的需求。對高通量篩檢、精準醫療和細胞生物學研究的日益重視將進一步推動其應用。技術進步、政府措施和市場需求的結合，使亞太地區成為全球自動化顯微鏡市場成長最快的地區。

免費客製化服務

訂閱此報告的用戶將獲得以下免費自訂選項之一：

公司簡介
- 對最多三家其他市場公司進行全面分析
- 主要企業的SWOT分析（最多3家公司）
區域細分
- 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
競爭基準化分析
- 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 其他歐洲國家
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 其他南美
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東和非洲地區

第9章：主要進展

協議、夥伴關係、合作和合資企業
收購與合併
新產品發布
業務擴展
其他關鍵策略

第10章：企業概況

Bruker Corporation
Carl Zeiss AG
Hitachi High-Tech-Technologies Corporation
JEOL Ltd.
Nikon Corporation
Olympus Corporation
Thermo Fisher Scientific Inc.
NanoEnTek Inc.
Molecular Devices LLC
Intelligent Imaging Innovations（3I）
Agilent Technologies, Inc.
Horiba Scientific
PerkinElmer
Keyence Corporation
Andor Technology

簡介目錄圖表

Product Code: SMRC31480

According to Stratistics MRC, the Global Automated Microscopy Market is accounted for $8.82 billion in 2025 and is expected to reach $15.62 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Automated microscopy represents a significant advancement in laboratory research and medical diagnostics, offering high-speed imaging and precise examination of biological specimens with limited human input. Combining robotics, cutting-edge optical systems, and intelligent software, these platforms can efficiently capture, process, and evaluate vast numbers of images, improving both speed and accuracy. Commonly used in areas such as cell biology, pathology, pharmaceutical testing, and clinical analysis, automated microscopy ensures uniform and reproducible outcomes. By minimizing manual intervention, it accelerates data collection and enables sophisticated quantitative studies, including counting cells, analyzing structures, and measuring fluorescence. This technology is essential for enhancing research productivity, diagnostic precision, and experimental consistency.

According to data from the National Institutes of Health (NIH), U.S. federal funding for biomedical research exceeded $45 billion in 2023, with a significant portion allocated to imaging technologies for cancer, neuroscience, and infectious disease research. Automated microscopy systems are central to high-throughput imaging in these domains.

Market Dynamics:

Driver:

Increasing demand for high-throughput imaging

The rising necessity for high-speed imaging in biomedical research and healthcare diagnostics significantly propels the automated microscopy market. Conventional manual microscopes are inadequate for handling large sample volumes efficiently. Automated platforms facilitate rapid, accurate, and reproducible imaging, allowing extensive sample analysis with reduced human effort. This requirement is driven by innovations in genomics, pharmaceutical development, and personalized treatment, where substantial data must be analyzed swiftly. Automated microscopy helps minimize errors, accelerates experimental workflows, and enhances productivity, supporting large-scale studies and clinical evaluations that demand consistency, precision, and efficiency in image acquisition and sample assessment.

Restraint:

High cost of automated microscopy systems

Expensive initial purchase and ongoing maintenance of automated microscopy systems significantly hinder market expansion. Cutting-edge platforms featuring advanced optics, robotic mechanisms, and integrated software demand high investment, limiting affordability for smaller labs and research institutions. Operational costs are further amplified by routine maintenance, software updates, and staff training requirements. These financial challenges slow adoption, especially in developing regions with constrained budgets. Although automated systems provide efficiency and accuracy benefits, the substantial cost associated with acquiring and operating such equipment remains a major obstacle to widespread utilization in scientific research and clinical diagnostic settings globally.

Opportunity:

Integration with artificial intelligence and machine learning

The convergence of automated microscopy with AI and ML offers significant market opportunities. Machine learning algorithms can process and interpret complex image datasets, identify subtle trends, and generate predictive insights beyond manual capabilities. This integration enhances experimental accuracy, speed, and reproducibility, allowing large-scale studies to be conducted efficiently. Increasing adoption in drug discovery, clinical diagnostics, and high-content screening highlights the benefits of AI-enhanced imaging. Combining intelligent algorithms with automated microscopy expands applications, streamlines workflows, and supports informed decision-making. As AI-driven solutions continue to advance, their integration with automated microscopy presents a major avenue for innovation and market expansion across research and healthcare sectors.

Threat:

Intense competition among market players

The automated microscopy market is challenged by strong competition among existing players and new entrants, posing a considerable threat to growth. Leading companies regularly introduce innovative solutions, creating price pressures and necessitating constant upgrades. Smaller and mid-tier firms may find it difficult to preserve market share due to limited capital and lower visibility. Competitive pressures can lead to reduced profit margins and increased spending on research, development, and marketing. The combination of intense rivalry and rapid technological advancement makes it difficult for companies to maintain long-term stability, representing a key threat to the sustained expansion of the global automated microscopy market.

Covid-19 Impact:

The COVID-19 outbreak exerted both restrictive and stimulative effects on the automated microscopy market. Initial lockdowns, disruptions in supply chains, and limited laboratory access slowed equipment purchases and delayed ongoing research activities. Reduced operations in many research and clinical labs temporarily hindered routine imaging and sample analysis. Conversely, the pandemic boosted demand for automated microscopy platforms in vaccine research, virus detection, and antiviral drug screening. These systems enabled rapid, high-throughput imaging and precise monitoring of cellular responses. Thus, despite short-term setbacks, COVID-19 underscored the critical role of automation in diagnostics and biomedical research, ultimately fostering long-term opportunities for growth in the automated microscopy market.

The inverted microscopes segment is expected to be the largest during the forecast period

The inverted microscopes segment is expected to account for the largest market share during the forecast period, owing to their broad utility in biomedical and life sciences research. By enabling observation of living cells and cultures from below, they are particularly suited for cell studies, pharmaceutical screening, and tissue research. Their seamless integration with automated imaging platforms, software-assisted analysis, and high-throughput workflows enhances laboratory efficiency and accuracy. Inverted microscopes provide reproducible, precise, and non-destructive imaging, making them essential in modern laboratories. Their flexibility in supporting diverse experimental designs and compatibility with advanced technologies secures their top position among all automated microscopy segments.

The life sciences & biomedical research segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the life sciences & biomedical research segment is predicted to witness the highest growth rate. This surge is fueled by the increasing need for sophisticated imaging in cell biology, genomics, and proteomic research. Automated systems allow rapid, high-throughput sample analysis, detailed visualization of cellular components, and precise quantitative measurements essential for advanced studies. Growing emphasis on personalized therapies, regenerative medicine, and innovative biomedical research drives strong adoption. Research institutions and laboratories are prioritizing investments in automated microscopy to enhance reproducibility, efficiency, and analytical accuracy, positioning life sciences and biomedical research as the segment with the most accelerated growth globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by robust healthcare infrastructure, prominent research institutions, and a high density of industry leaders. Substantial investments in biotechnology, pharmaceuticals, and life sciences research fuel demand for automated imaging systems. Government initiatives, technological adoption, and emphasis on personalized medicine contribute to strong market expansion. The extensive utilization of automated microscopy across academic, clinical, and industrial laboratories-for applications such as cell biology, biomedical research, and drug development-reinforces the region's dominance. North America's combination of advanced infrastructure, funding, and research expertise secures its position as the leading market for automated microscopy globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Growth is fueled by rising healthcare infrastructure investments, expanding biotechnology and life sciences research, and government support for innovation and diagnostics. Rapid development in pharmaceutical and biopharmaceutical industries drives strong demand for automated imaging platforms in laboratories, research centers, and clinical institutions. Increasing emphasis on high-throughput screening, precision medicine and cell biology studies which will further boosts adoption. This combination of technological advancement, government initiatives, and market demand positions Asia Pacific as the region with the most accelerated growth in the global automated microscopy market.

Key players in the market

Some of the key players in Automated Microscopy Market include Bruker Corporation, Carl Zeiss AG, Hitachi High-Tech-Technologies Corporation, JEOL Ltd., Nikon Corporation, Olympus Corporation, Thermo Fisher Scientific Inc., NanoEnTek Inc., Molecular Devices LLC, Intelligent Imaging Innovations (3I), Agilent Technologies, Inc., Horiba Scientific, PerkinElmer, Keyence Corporation and Andor Technology.

Key Developments:

In August 2025, Bruker Corporation announced the signing of multiple new contracts and framework agreements for its explosives and chemical trace detection solutions, accessories, consumables, and service offerings. Finalized throughout 2025, these agreements represent a total order volume of over $27 million year-to-date in 2025, supporting customers in the aviation security and defense industry to enhance threat detection capabilities.

In June 2025, Carl Zeiss Vision International GmbH announced that it has entered a definitive agreement to acquire 100% of the shares in Brighten Optix, listed on Taipei Exchange. Brighten Optix is a leading player in the field of orthokeratology and specialty contact lenses. The capability and products of Brighten Optix will now play an important role in ZEISS Vision Care's long-term strategy and success.

In June 2025, Hitachi High-Tech has entered into a contractual agreement of collaboration with the Petroleum and Petrochemical College (PPC) of Chulalongkorn University. With this agreement, Hitachi High-Tech Group will contribute to the creation of new industrial values by pushing data science education forward, enhancing social implementations of research results, and partnerships between industry and academic institutions.

Product Types Covered:

Inverted Microscopes
Fluorescence Microscopes
Electron Microscopes
Scanning Probe Microscopes
Optical Microscopes
Super-Resolution Microscopes
Confocal Microscopes

Applications Covered:

Life Sciences & Biomedical Research
Clinical Diagnostics
Drug Discovery
Cell Biology & Neuroscience
Microbiology
Semiconductors
Nanotechnology & Material Science

End Users Covered:

Academic & Research Institutions
Pharmaceutical & Biotechnology Companies
Clinical & Diagnostic Laboratories
Hospitals & Healthcare Facilities
Contract Research Organizations (CRO)

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Automated Microscopy Market, By Product Type

5.1 Introduction
5.2 Inverted Microscopes
5.3 Fluorescence Microscopes
5.4 Electron Microscopes
5.5 Scanning Probe Microscopes
5.6 Optical Microscopes
5.7 Super-Resolution Microscopes
5.8 Confocal Microscopes

6 Global Automated Microscopy Market, By Application

6.1 Introduction
6.2 Life Sciences & Biomedical Research
6.3 Clinical Diagnostics
6.4 Drug Discovery
6.5 Cell Biology & Neuroscience
6.6 Microbiology
6.7 Semiconductors
6.8 Nanotechnology & Material Science

7 Global Automated Microscopy Market, By End User

7.1 Introduction
7.2 Academic & Research Institutions
7.3 Pharmaceutical & Biotechnology Companies
7.4 Clinical & Diagnostic Laboratories
7.5 Hospitals & Healthcare Facilities
7.6 Contract Research Organizations (CRO)

8 Global Automated Microscopy Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Bruker Corporation
10.2 Carl Zeiss AG
10.3 Hitachi High-Tech-Technologies Corporation
10.4 JEOL Ltd.
10.5 Nikon Corporation
10.6 Olympus Corporation
10.7 Thermo Fisher Scientific Inc.
10.8 NanoEnTek Inc.
10.9 Molecular Devices LLC
10.10 Intelligent Imaging Innovations (3I)
10.11 Agilent Technologies, Inc.
10.12 Horiba Scientific
10.13 PerkinElmer
10.14 Keyence Corporation
10.15 Andor Technology

簡介目錄圖表

List of Tables

Table 1 Global Automated Microscopy Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Automated Microscopy Market Outlook, By Product Type (2024-2032) ($MN)
Table 3 Global Automated Microscopy Market Outlook, By Inverted Microscopes (2024-2032) ($MN)
Table 4 Global Automated Microscopy Market Outlook, By Fluorescence Microscopes (2024-2032) ($MN)
Table 5 Global Automated Microscopy Market Outlook, By Electron Microscopes (2024-2032) ($MN)
Table 6 Global Automated Microscopy Market Outlook, By Scanning Probe Microscopes (2024-2032) ($MN)
Table 7 Global Automated Microscopy Market Outlook, By Optical Microscopes (2024-2032) ($MN)
Table 8 Global Automated Microscopy Market Outlook, By Super-Resolution Microscopes (2024-2032) ($MN)
Table 9 Global Automated Microscopy Market Outlook, By Confocal Microscopes (2024-2032) ($MN)
Table 10 Global Automated Microscopy Market Outlook, By Application (2024-2032) ($MN)
Table 11 Global Automated Microscopy Market Outlook, By Life Sciences & Biomedical Research (2024-2032) ($MN)
Table 12 Global Automated Microscopy Market Outlook, By Clinical Diagnostics (2024-2032) ($MN)
Table 13 Global Automated Microscopy Market Outlook, By Drug Discovery (2024-2032) ($MN)
Table 14 Global Automated Microscopy Market Outlook, By Cell Biology & Neuroscience (2024-2032) ($MN)
Table 15 Global Automated Microscopy Market Outlook, By Microbiology (2024-2032) ($MN)
Table 16 Global Automated Microscopy Market Outlook, By Semiconductors (2024-2032) ($MN)
Table 17 Global Automated Microscopy Market Outlook, By Nanotechnology & Material Science (2024-2032) ($MN)
Table 18 Global Automated Microscopy Market Outlook, By End User (2024-2032) ($MN)
Table 19 Global Automated Microscopy Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
Table 20 Global Automated Microscopy Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 21 Global Automated Microscopy Market Outlook, By Clinical & Diagnostic Laboratories (2024-2032) ($MN)
Table 22 Global Automated Microscopy Market Outlook, By Hospitals & Healthcare Facilities (2024-2032) ($MN)
Table 23 Global Automated Microscopy Market Outlook, By Contract Research Organizations (CRO) (2024-2032) ($MN)